Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969880257> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1969880257 endingPage "522" @default.
- W1969880257 startingPage "519" @default.
- W1969880257 abstract "Malignant carcinoid tumors with the carcinoid syndrome has over the years presented a therapeutic challenge. Surgery is the treatment of choice in local disease but when liver metastases have developed other treatment procedures must be considered. Conventional chemotherapy has been of little benefit, whereas a new somatostatin analogue octreotide gives a good control of clinical symptoms but not of tumor progression. Interferon treatment was introduced in 1982 by our group and we are now presenting results of medical treatment in 130 patients with histologically verified malignant carcinoid tumors and liver metastases. One hundred and eleven patients were treated with α-interferon, whereas 19 patients received conventional chemotherapy. Forty-seven out of 111 patients (42%) treated with a-interferon demonstrated a significant biochemical response and 15% also more than 50% reduction of tumor size. in another 43 (39%) patients stabilization of the carcinoid disease was noted whereas 21 (19%) showed progressive disease. the median duration of response was 34 months. Subjective response with improvement of diarrheas, flush and/or bronchoconstriction was noticed in 76 patients (68%). Among the 19 patients treated with conventional chemotherapy only 2 showed biochemical response and it lasted only for 3-5 months. the patients treated with chemotherapy had a median survival of only 8 months compared with 80+ months in the group treated with α-interferon. the adverse reactions of α-interferon are manageable and consist mainly of fatigue, weight reduction and reduction of blood cell counts. Neutralizing interferon antibodies might occur in patients treated with recombinant α-interferons (5-15%)." @default.
- W1969880257 created "2016-06-24" @default.
- W1969880257 creator A5009862688 @default.
- W1969880257 creator A5040645190 @default.
- W1969880257 date "1991-01-01" @default.
- W1969880257 modified "2023-09-27" @default.
- W1969880257 title "The Role of Interferons in the Management of Carcinoid Tumors" @default.
- W1969880257 cites W1966669049 @default.
- W1969880257 cites W2009934924 @default.
- W1969880257 cites W2010499248 @default.
- W1969880257 cites W2011739365 @default.
- W1969880257 cites W2086133857 @default.
- W1969880257 cites W2337135362 @default.
- W1969880257 doi "https://doi.org/10.3109/02841869109092411" @default.
- W1969880257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1854509" @default.
- W1969880257 hasPublicationYear "1991" @default.
- W1969880257 type Work @default.
- W1969880257 sameAs 1969880257 @default.
- W1969880257 citedByCount "112" @default.
- W1969880257 countsByYear W19698802572012 @default.
- W1969880257 countsByYear W19698802572013 @default.
- W1969880257 countsByYear W19698802572015 @default.
- W1969880257 countsByYear W19698802572016 @default.
- W1969880257 countsByYear W19698802572017 @default.
- W1969880257 countsByYear W19698802572018 @default.
- W1969880257 countsByYear W19698802572020 @default.
- W1969880257 crossrefType "journal-article" @default.
- W1969880257 hasAuthorship W1969880257A5009862688 @default.
- W1969880257 hasAuthorship W1969880257A5040645190 @default.
- W1969880257 hasBestOaLocation W19698802571 @default.
- W1969880257 hasConcept C126322002 @default.
- W1969880257 hasConcept C141071460 @default.
- W1969880257 hasConcept C143998085 @default.
- W1969880257 hasConcept C197934379 @default.
- W1969880257 hasConcept C203014093 @default.
- W1969880257 hasConcept C2776178377 @default.
- W1969880257 hasConcept C2776297358 @default.
- W1969880257 hasConcept C2776694085 @default.
- W1969880257 hasConcept C2781025020 @default.
- W1969880257 hasConcept C2781151469 @default.
- W1969880257 hasConcept C2781228144 @default.
- W1969880257 hasConcept C2909179924 @default.
- W1969880257 hasConcept C71924100 @default.
- W1969880257 hasConcept C90924648 @default.
- W1969880257 hasConceptScore W1969880257C126322002 @default.
- W1969880257 hasConceptScore W1969880257C141071460 @default.
- W1969880257 hasConceptScore W1969880257C143998085 @default.
- W1969880257 hasConceptScore W1969880257C197934379 @default.
- W1969880257 hasConceptScore W1969880257C203014093 @default.
- W1969880257 hasConceptScore W1969880257C2776178377 @default.
- W1969880257 hasConceptScore W1969880257C2776297358 @default.
- W1969880257 hasConceptScore W1969880257C2776694085 @default.
- W1969880257 hasConceptScore W1969880257C2781025020 @default.
- W1969880257 hasConceptScore W1969880257C2781151469 @default.
- W1969880257 hasConceptScore W1969880257C2781228144 @default.
- W1969880257 hasConceptScore W1969880257C2909179924 @default.
- W1969880257 hasConceptScore W1969880257C71924100 @default.
- W1969880257 hasConceptScore W1969880257C90924648 @default.
- W1969880257 hasIssue "4" @default.
- W1969880257 hasLocation W19698802571 @default.
- W1969880257 hasLocation W19698802572 @default.
- W1969880257 hasOpenAccess W1969880257 @default.
- W1969880257 hasPrimaryLocation W19698802571 @default.
- W1969880257 hasRelatedWork W1969880257 @default.
- W1969880257 hasRelatedWork W1985473100 @default.
- W1969880257 hasRelatedWork W2012174757 @default.
- W1969880257 hasRelatedWork W2016416363 @default.
- W1969880257 hasRelatedWork W2113286278 @default.
- W1969880257 hasRelatedWork W2131492952 @default.
- W1969880257 hasRelatedWork W2165147224 @default.
- W1969880257 hasRelatedWork W222181788 @default.
- W1969880257 hasRelatedWork W2404099963 @default.
- W1969880257 hasRelatedWork W2014450888 @default.
- W1969880257 hasVolume "30" @default.
- W1969880257 isParatext "false" @default.
- W1969880257 isRetracted "false" @default.
- W1969880257 magId "1969880257" @default.
- W1969880257 workType "article" @default.